New insights into the pathogenesis of bullous pemphigoid: 2019 update

G Genovese, G Di Zenzo, E Cozzani, E Berti… - Frontiers in …, 2019 - frontiersin.org
There are several lines of evidence indicating that the physiopathological bases of bullous
pemphigoid (BP), the most common subepidermal autoimmune bullous disease, are …

Dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid

K Tasanen, O Varpuluoma, W Nishie - Frontiers in immunology, 2019 - frontiersin.org
Bullous pemphigoid (BP) is an organ-specific autoantibody-mediated blistering skin disease
that mainly affects the elderly. Typical clinical features include the widespread blisters, often …

The role of eosinophils in bullous pemphigoid: a developing model of eosinophil pathogenicity in mucocutaneous disease

KT Amber, M Valdebran, K Kridin, SA Grando - Frontiers in Medicine, 2018 - frontiersin.org
Bullous pemphigoid (BP) is an autoimmune blistering disease which carries a significant
mortality and morbidity. While historically BP has been characterized as an IgG driven …

The diagnosis and blistering mechanisms of mucous membrane pemphigoid

M Kamaguchi, H Iwata - Frontiers in Immunology, 2019 - frontiersin.org
Mucous membrane pemphigoid (MMP) is a mucous membrane-dominated autoimmune
subepithelial blistering disease that is caused by autoantibodies against various …

Bullous pemphigoid in diabetic patients treated by gliptins: the other side of the coin

K Chouchane, G Di Zenzo, D Pitocco… - Journal of Translational …, 2021 - Springer
Bullous pemphigoid (BP) is the most common autoimmune bullous skin disease that affects
primarily patients older than 60 years. The majority of BP cases are spontaneous, but BP …

Rituximab therapy in patients with bullous pemphigoid: a retrospective study of 20 patients

M Polansky, R Eisenstadt, T DeGrazia, X Zhao… - Journal of the American …, 2019 - Elsevier
Background Bullous pemphigoid (BP) is the most common autoimmune blistering disease
requiring treatment with immunosuppressive medications; however, finding a therapy that …

Assessment of the prevalence of mucosal involvement in bullous pemphigoid

K Kridin, R Bergman - JAMA dermatology, 2019 - jamanetwork.com
Importance The prevalence of mucosal involvement in bullous pemphigoid (BP) is
inconsistent. Nonoral mucosal involvement was reported anecdotally in few patients with …

Bullous pemphigoid: the role of type 2 inflammation in its pathogenesis and the prospect of targeted therapy

L Zhang, Z Chen, L Wang, X Luo - Frontiers in Immunology, 2023 - frontiersin.org
Bullous pemphigoid (BP) is an autoimmune disease that mainly occurs in the elderly,
severely affecting their health and life quality. Traditional therapy for BP is mainly based on …

Eosinophilic dermatoses: recognition and management

AV Marzano, G Genovese - American Journal of Clinical Dermatology, 2020 - Springer
Eosinophilic dermatoses encompass a broad spectrum of diseases of different etiologies
hallmarked by eosinophilic infiltration of the skin and/or mucous membranes, with or without …

Emerging biomarkers and therapeutic strategies for refractory bullous pemphigoid

T Zhou, B Peng, S Geng - Frontiers in Immunology, 2021 - frontiersin.org
Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disorder
in the elderly. Systemic and topical use of glucocorticoids and immunosuppressants has …